Table 2.
Vitamin K dependent procoagulant clotting factor activities before and after rituximab and chlorambucil treatment
| Parameter | BT | AT | Normal range (%) |
|---|---|---|---|
| Factor II | 63 | 86 | 80–120 |
| Factor VII | 54 | 106 | 65–150 |
| Factor IX | 53 | 102 | 70–140 |
| Factor X (extrinsic) | 8 | 106 | 80–120 |
BT, before treatment; AT, after treatment.